首页> 外文期刊>Journal of Clinical and Diagnostic Research >Evaluation of Percutaneous Vertebroplasty for Management of Symptomatic Osteoporotic Compression Fracture RC07-RC10
【24h】

Evaluation of Percutaneous Vertebroplasty for Management of Symptomatic Osteoporotic Compression Fracture RC07-RC10

机译:经皮椎体成形术治疗症状性骨质疏松性压缩性骨折RC07-RC10的评估

获取原文
           

摘要

Introduction: Osteoporotic vertebral compression fractures are a leading cause of disability and associated morbidities among Indian population. Worldwide, approximately 20% of elderly population above 70 years and 16% of postmenopausal women are suffering from it. Vertebral compression fractures should be aggressively treated with minimally invasive techniques such as Percutaneous Vertebroplasty (PVP) or Percutaneous Kyphoplasty (PKP) to minimize pain and disability associated with it.Aim: To evaluate the PVP in terms of pain reduction and restoration of functional abilities among the patients suffering from symptomatic osteoporotic vertebral compression fracture.Materials and Methods: PVP using polymethyl methacrylate bone cement was performed between 2011 to 2013, on 25 patients admitted for symptomatic osteoporotic vertebral compression fracture in the Department of Orthopaedics, Institute of Post Graduate Medical Education and Research (IPGMER) and SSKM Hospital, Kolkata, West Bengal, India. All of them were followed up for one year. Pain and disability were evaluated with Visual Analogue Scale (VAS) and Oswestry Disability Questionnaire (ODQ) score respectively. Repeated measures ANOVA with Bonferroni post-hoc test was applied for significance testing.Results: Reduction in pain was reported by 56% of patients within 10 minutes of operation. Mean VAS score at presentation was 8.24 (±1.16). It reduced to 6.31 (±1.21) and 2.38 (±0.08) at immediate postoperative period and after 12 months respectively. There was significant reduction (p<0.05) in pain, as measured by VAS score, started at immediate postoperative period to end of follow up period up to one year. Disability, measured by ODQ score, significantly decrease (p<0.05) over time from one week to 12-month postoperatively. At presentation, ODQ score was 93.01 (±4.54). It reduced to 76.84 (±3.76), one week after operation and 16.23 (±1.17), one year after operation.Conclusion: The PVP with polymethayl methacrylate bone cement is still a justified treatment procedure for osteoporotic vertebral compression fractures as it provides excellent pain relief, internal stability to the fractured vertebra thus preventing further collapse and progression of kyphosis, allowing the patients to regain normal activity at the earliest, and at a very reasonable cost with minimal complication.
机译:简介:骨质疏松性椎体压缩性骨折是印度人口致残和相关疾病的主要原因。在世界范围内,大约20%的70岁以上的老年人口和16%的绝经后妇女正遭受这种疾病的困扰。椎体压缩性骨折应采用微创技术积极治疗,例如经皮椎体成形术(PVP)或经皮椎体后凸成形术(PKP),以最大程度地减少与之相关的疼痛和残障。目的:从减轻疼痛和恢复功能能力方面评估PVP。材料与方法:2011年至2013年间,对25例因骨质疏松性椎体压缩性骨折而患有骨质疏松性椎体压缩性骨折的患者,对研究生医学教育研究所和骨科的25例因骨质疏松性椎体压缩性骨折而收治的患者进行了研究。印度西孟加拉邦加尔各答的研究(IPGMER)和SSKM医院。他们都被随访了一年。疼痛和残疾分别通过视觉模拟量表(VAS)和Oswestry残疾问卷(ODQ)评分进行评估。结果:在手术10分钟内,有56%的患者报告疼痛减轻。演示时的VAS平均得分为8.24(±1.16)。术后即刻和术后12个月时分别降至6.31(±1.21)和2.38(±0.08)。以VAS评分为标准,从术后即刻至随访期长达一年,疼痛明显减轻(p <0.05)。从ODQ评分衡量的残疾从术后1周到12个月随时间显着减少(p <0.05)。在演示时,ODQ得分为93.01(±4.54)。术后一周减少至76.84(±3.76),术后一年减少至16.23(±1.17)。结论:聚甲基丙烯酸甲基丙烯酸甲酯骨水泥的PVP仍可作为治疗骨质疏松性椎体压缩性骨折的合理方法,因为它可提供出色的疼痛感这样就可以减轻骨折椎骨的内部稳定性,从而防止脊椎后凸的进一步塌陷和发展,使患者尽早并以非常合理的成本恢复正常活动,并减少并发症的发生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号